T9	Treatment 0 90	Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently
T10	Subject 142 193	postmenopausal node-positive breast cancer patients
T13	Drug 55 64	tamoxifen
T15	Drug 0 27	Epirubicin-cyclophosphamide
T16	Treat-Disorder 157 184	node-positive breast cancer
T14	Combination 50 54	plus
T11	Potential_therapeutic_event 65 77	administered
E2	Combination:T14 arg:T13 arg2:T15
E1	Potential_therapeutic_event:T11